Post by
Pareto8020 on Jun 18, 2024 11:22am
News response
Seems to be a tepid response to the write-up with a paltry 40 shares traded so far.
This is a "show me the money" stock now and until they do that it likely isn't going to see a tremendous amount of action.
If they could announce some AbbVie milestones or royalties on the near horizon that would be an ideal catalyst to jolt this back to life.
Comment by
lscfa on Jun 18, 2024 11:54am
The full report: does not say SBM is a publicly traded co, does not provide a valuation on SBM, does not provide any timing other than GPM to lauch in 2025